Stephen George, PharmD, MS | SVP Market Access Reimbursment
Milliman

Stephen George, PharmD, MS, SVP Market Access Reimbursment, Milliman

Stephen is a pharmacist with over 30 years of experience. He has held several leadership roles within the healthcare industry.. He has a successful track record directed at improving the patient experience and outcomes. He strives for excellence with a strategic focus and strong work ethic build around integrity. He has managed multi-disciplinary teams around efficiency and innovation. He has delivered on top line corporate revenue growth within the healthcare market.As a clinician he has direct patient care and management experience in a variety of settings - managed care, hospital, and clinical trials. Additionally, he has developed commercial and Part-D medical clinical programs, designed HEOR studies, audited 340‐B pricing models, priced drugs/devices, and priced value-based contracts. Professional Work Experience Previous positions include:· Co-owner Conexus Health and Clinical Pharmacology ServicesPharmacy Advisor Hillsborough County Healthcare PlanPharmacy Director Physician Corporation of AmericaClinical Pharmacist Mount Carmel Medical Center (MCMC) Professional Designations Stephen holds a Florida pharmacist license and continues to practice in patient care. Education

  • PharmD, Broadmore University
  • MS Hospital Pharmacy Administration,The Ohio State University·
  • Bachelor Science Pharmacy, Samford University·
  • Chief Administrative Pharmacy Resident, MCMC, Columbus, OH·
  • Pharmacy Practice Resident, MCMC, Columbus, OH·
  • Pharmacy Practice Resident, Medical University of South Carolina, Charleston
Presentations and Publications He has published and/or presented numerous manuscripts, abstracts, strategy sessions, and podium presentations. He has participated as co‐investigator in several Phase II-IV clinical trials.

Appearances:



Pre-Conference Day - World Orphan Drug Congress USA 2025 @ 12:55

Chairperson's opening remarks

Pre-Conference Day - World Orphan Drug Congress USA 2025 @ 14:55

Chairperson's opening remarks

Pre-Conference Day - World Orphan Drug Congress USA 2025 @ 15:00

Workshop: Medicare IRA practical experience on stakeholder value for orphan conditions

In this workshop, the actuarial and clinical experts will share their experiences and data. The Inflation Reduction Act (IRA) places greater financial liability on both biotech and Medicare Plan Sponsors. The experts will share their experiences and data on how the IRA influences Medicare stakeholders. The workshop will highlight practical solutions to engage stakeholder value and provide payer insights into reimbursement challenges for the biotech industry.

last published: 24/Apr/25 11:35 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

Connect with us

 
 
 
 

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Kaylee Nguyen
kaylee.nguyen@terrapinn.com
 

 

 

 

Marketing & Press

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com